Delivery Order SPE2DB20D1047-SPE2DB24FF47X
Award Date
2/21/24
Potential Completion Date
2/22/24
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,054.01 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 3, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA). The $10,582.53 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 30, 2024 with a completion date of May 1, 2024. This is a firm-fixed price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML pharmaceutical products to the Defense Logistics Agency (DLA). The award, valued at $10,861.95, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 28, 2023. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The contract, valued at $4,647.12, is a Delivery Order with a Firm Fixed Price pricing type. It was awarded on July 11, 2024, with a completion date of July 12, 2024. This award is...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA). The $17,414.44 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 14, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML syringes to the Defense Logistics Agency (DLA) Troop Support Medical program. The $10,240.87 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract has an ultimate completion date of April 2, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML pharmaceutical products to the Defense Logistics Agency (DLA). The $4,647.12 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 29, 2024. The contract has an ultimate completion date of April 30, 2024 and was not designated as a set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $12,882.17 and a completion date of September 28, 2023. The award was not designated with a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,355.23 firm fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The award has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,767.52, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...